Discusses AD at a molecular level, from the misfolding and aggregation of amyloid-beta and tau proteins to disruptions in cellular homeostasis, mitochondrial dysfunction, and neuroinflammation. Presents new therapeutics for neurodegenerative disorders, behavioral intervention.
Inhaltsverzeichnis
Preface 1. Investigating the Role of Amyloid Beta and Tau Peptides in Alzheimer's Histopathological Brain Lesions 2. Advances in Comprehending Cholinergic System and Emerging Tools to Novel Therapeutics 3. Current Progress in Mono Amino Oxidase Inhibitors in Anti-Alzheimer's Therapy: An Understanding into Therapeutic Prospects of Inhibitors 4. Assimilation of Transgenic Modeling Methods of Alzheimer's Disease: Mechanism of Neurodegeneration 5. Methods for Tailoring Medicines for Alzheimer's Disease Treatment: Customizing Therapies According to Individual Genetic and Molecular Characteristics 6. Ethical Considerations in Field of Alzheimer's Research and Overcoming Obstacles in Clinical Trials and Ethical of Research 7. International Efforts in Alzheimer's Research and Treatment: A Worldwide Outlook on Alzheimer's Disease 8. Role of Neurotrophins in Alzheimer's Disease Pathogenesis to Develop Novel Therapeutics 9. Behavioral Intervention and Cognitive Training in Disease Management in Alzheimer's Disease 10. Therapeutic Potential of NMDA Receptors in Alzheimer's Disease 11. Unrevealing the Insights of NMDA Receptors in Neurodegenerative Disorders 12. Pharmacological Modulation of Neurodegenerative Disorders: Therapeutic Potential and Persisting Obstacles Index